al, 2004). A metabolic impairment of the neuromuscular junction can be caused by the lack of AChE or mutation in AChE that makes the enzyme not able to hydrolyze acetylcholine, so now it remains present in the cell. This is problematic because stimulation of a receptor results in the receptor becoming less efficient at producing a signal. The immune mediated cause for neuromuscular junction malfunction is due to the body attacking the acetylcholine receptors. In the acquired immunity process, an immune cell undergoes specialization so that it can produce antibodies that correlate to foreign threats that can enter the body. Sometimes, this process malfunctions, and this creates an autoimmune disease. In this case, antibodies are produced that attack the acetylcholine receptors, and this leads to a decrease of acetylcholine receptors (Fambrough et. al, 1973). Since the neurons are not effectively recognizing the acetylcholine, it causes the person suffering with this condition to have impaired movement, or weakness. The name of that condition is called myasthenia gravis. Myasthenia gravis can become especially troublesome if the muscles that control breathing are weakened to a severe extent. Treatment for this condition involves immunosuppressant drugs to reduce the amount
al, 2004). A metabolic impairment of the neuromuscular junction can be caused by the lack of AChE or mutation in AChE that makes the enzyme not able to hydrolyze acetylcholine, so now it remains present in the cell. This is problematic because stimulation of a receptor results in the receptor becoming less efficient at producing a signal. The immune mediated cause for neuromuscular junction malfunction is due to the body attacking the acetylcholine receptors. In the acquired immunity process, an immune cell undergoes specialization so that it can produce antibodies that correlate to foreign threats that can enter the body. Sometimes, this process malfunctions, and this creates an autoimmune disease. In this case, antibodies are produced that attack the acetylcholine receptors, and this leads to a decrease of acetylcholine receptors (Fambrough et. al, 1973). Since the neurons are not effectively recognizing the acetylcholine, it causes the person suffering with this condition to have impaired movement, or weakness. The name of that condition is called myasthenia gravis. Myasthenia gravis can become especially troublesome if the muscles that control breathing are weakened to a severe extent. Treatment for this condition involves immunosuppressant drugs to reduce the amount